Note 20 - Segment and Geographic Information

12 Months Ended

May 31, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

20. SEGMENT AND GEOGRAPHIC INFORMATION

The Company determines operating segments in accordance with its internal operating structure, which is organized based upon product groups. Each segment is separately managed and is evaluated primarily upon operating results. The Company has two operating segments, the Transfusion segment and the Transplant & Molecular segment, which have been aggregated into one reportable segment.

The Company manufactures and markets a complete line of diagnostics products and automated systems used primarily by hospitals, donor centers and reference laboratories in a number of tests performed to detect and identify certain properties of human blood and human tissue to enable the most compatible match available between patient and donor. These tests are performed for the purpose of blood transfusions and organ and stem cell transplantations.

The Company operates in various geographies. These geographic markets are comprised of the United States, Europe, Canada and other international markets. The majority of the other international markets are considered emerging markets for our business. These products are marketed globally, both directly to the end user and through established distributors.

Accounting policies for segments are the same as those described in the summary of significant accounting policies.

The following segment data is presented for the years ended May 31, 2016, 2015, and 2014 as follows (in thousands):

	Year Ended May 31
	2016		2015		2014
Net sales by product group:
Transfusion	$	317,345		326,850		330,547
Transplant & Molecular		62,627		62,450		57,509
Total	$	379,972		389,300		388,056

Following is a summary of enterprise-wide information (in thousands):

	Year Ended May 31
	2016		2015		2014
Net sales to customers by geography are as follows:
United States	$	241,199		238,639		239,204
Europe (A)		70,630		77,820		79,219
Canada		15,576		19,260		19,127
Other		52,567		53,581		50,506
Total	$	379,972		389,300		388,056

Net sales are attributed to individual countries based on the customer's country of origin at the time of

the sale and where the Company has an operating entity.

	As of May 31
	2016		2015
Long-lived assets (excluding goodwill and intangibles) by geography:
United States	$	55,080		52,764
Europe (B)		14,729		14,542
Canada		3,543		4,029
Other (C)		2,663		2,239
Total	$	76,015		73,574

	As of May 31
	2016		2015
Concentration of net assets by geography:
United States	$	200,226		241,522
Europe		102,593		100,071
Canada		28,617		30,274
Other (C)		13,110		11,814
Total	$	344,546		383,681

(A) - Net sales to any individual country within Europe were not material to the Company's consolidated net sales.

(B) - Long-lived assets located in any individual country within Europe were not material to the Company's

consolidated long-lived assets.

(C ) - Primarily Japan and India

Sales to an individual customer did not exceed 10% or more of our annual net sales during any of the years ended May 31, 2016, 2015, or 2014.